Financial Trade Freedom - Investing and Stock News
  • Investing
  • News
  • Editor’s Pick
  • Economy
  • Stock
  • Investing
  • News
  • Editor’s Pick
  • Economy
  • Stock
No Result
View All Result
Financial Trade Freedom - Investing and Stock News
No Result
View All Result
Home News

Senate defies Trump on global tariffs as Republicans join Democrats in rare bipartisan vote

admin by admin
October 30, 2025
in News
0
Senate defies Trump on global tariffs as Republicans join Democrats in rare bipartisan vote
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

The Senate once again rejected President Donald Trump’s tariffs, this time on a global scale.

Lawmakers in the upper chamber went three for three with resolutions meant to terminate Trump’s use of emergency powers to enact steep tariffs on foreign countries. While the previous two were geared toward specific tariffs on Brazil and Canada, the latest would end tariffs on countries around the world.

Earlier this year, Trump declared through the International Emergency Economic Powers Act that he would enact a base 10% tariff on countries across the world. He argued in his executive order at the time that ‘national emergency arising from conditions reflected in large and persistent annual U.S. goods trade deficits’ as a reason to pull the trigger on the tariffs.

Since then, senators have grumbled about the tariffs and made moves to terminate his usage of emergency powers throughout the year.

And it’s the second time that this particular resolution from Sen. Ron Wyden, D-Ore., has been considered in the Senate.

The first go-round saw the resolution narrowly defeated 49-49, not because of partisan will but because of absences on the day of the vote. At the time, Sens. Mitch McConnell, R-Ky., and Sheldon Whitehouse, D-R.I., were expected to vote for the resolution but missed their chance.

Fast-forward to October, and McConnell joined a foursome of Republicans, including himself and Sens. Lisa Murkowski, R-Alaska, Susan Collins, R-Maine, and Rand Paul, R-Ky., to strike down Trump’s global tariffs. Those same lawmakers all voted against the previous two resolutions, too.

The other tariff-minded legislation would end Trump’s emergency powers to enact 50% tariffs on Brazilian goods and 35% tariffs on Canadian goods.

But they likely won’t go anywhere in the House, which previously voted to reject undermining Trump’s tariff policy until next year.

Meanwhile, Trump announced that after a ‘truly great’ meeting with Chinese President Xi Jinping that he would lower his fentanyl tariffs on China by 10%. That brings the total level of duties on the country down to 47% from 57%.

The reduction comes after China agreed to help stymie the flow of chemicals into the U.S. that are used to create the dangerous narcotic and to ease export controls on rare earth minerals, which manufacturers in the U.S. rely on to create a variety of goods and electronics.

‘There is enormous respect between our two countries, and that will only be enhanced with what just took place,’ Trump said on Truth Social. ‘We agreed on many things, with others, even of high importance, being very close to resolved.’

This post appeared first on FOX NEWS

Previous Post

Thune, GOP reject pushing ‘rifle-shot’ government funding bills during shutdown

Next Post

Republican senators blast FDA for expanding abortion pill access

Next Post
Republican senators blast FDA for expanding abortion pill access

Republican senators blast FDA for expanding abortion pill access

  • Trending
  • Comments
  • Latest
U.S. homebuilders raise alarm over tariffs as sentiment falls to 5-month low

U.S. homebuilders raise alarm over tariffs as sentiment falls to 5-month low

February 19, 2025
How Companies Use Derivatives To Hedge Risk

How Companies Use Derivatives To Hedge Risk

February 19, 2025
KFC moves U.S. headquarters from Kentucky to Texas

KFC moves U.S. headquarters from Kentucky to Texas

February 19, 2025
Synthetic: Definition in Finance, Types of Assets

Synthetic: Definition in Finance, Types of Assets

February 19, 2025
Is Nvidia next? Why is China lifting its ban on certain Nexperia chips

Is Nvidia next? Why is China lifting its ban on certain Nexperia chips

0
From tariffs to DOGE, what companies are saying about the impact of MAGA policies

From tariffs to DOGE, what companies are saying about the impact of MAGA policies

0
Tesla’s law firm drafts Delaware bill that could salvage Musk pay package

Tesla’s law firm drafts Delaware bill that could salvage Musk pay package

0
Coca-Cola takes on Olipop and Poppi with new prebiotic soda brand, Simply Pop

Coca-Cola takes on Olipop and Poppi with new prebiotic soda brand, Simply Pop

0
Is Nvidia next? Why is China lifting its ban on certain Nexperia chips

Is Nvidia next? Why is China lifting its ban on certain Nexperia chips

November 1, 2025
Pfizer sues to block Novo Nordisk’s bid for Metsera in high-stakes pharma clash

Pfizer sues to block Novo Nordisk’s bid for Metsera in high-stakes pharma clash

November 1, 2025
Berkshire Hathaway delivers blowout Q3 profit as Buffett’s cash mountain keeps growing

Berkshire Hathaway delivers blowout Q3 profit as Buffett’s cash mountain keeps growing

November 1, 2025
Inside big tech’s $400 billion AI race: brilliant strategy or bubble waiting to burst?

Inside big tech’s $400 billion AI race: brilliant strategy or bubble waiting to burst?

November 1, 2025

    Get Smarter with Your Money – Sign Up for Free Financial Tips!


    Join our community of savvy savers and investors! By signing up, you'll receive weekly emails packed with personalized financial tips, budgeting hacks, and investment strategies tailored to your income level. Take control of your finances today – it’s free and only takes a minute!

    Recent News

    Is Nvidia next? Why is China lifting its ban on certain Nexperia chips

    Is Nvidia next? Why is China lifting its ban on certain Nexperia chips

    November 1, 2025
    Pfizer sues to block Novo Nordisk’s bid for Metsera in high-stakes pharma clash

    Pfizer sues to block Novo Nordisk’s bid for Metsera in high-stakes pharma clash

    November 1, 2025
    Berkshire Hathaway delivers blowout Q3 profit as Buffett’s cash mountain keeps growing

    Berkshire Hathaway delivers blowout Q3 profit as Buffett’s cash mountain keeps growing

    November 1, 2025
    Inside big tech’s $400 billion AI race: brilliant strategy or bubble waiting to burst?

    Inside big tech’s $400 billion AI race: brilliant strategy or bubble waiting to burst?

    November 1, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: FinancialTradeFreedom.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 financialtradefreedom.com | All Rights Reserved

    No Result
    View All Result
    • About us
    • Contacts
    • Email Whitelisting
    • Investing and Stock News
    • Privacy Policy
    • Terms and Conditions
    • Thank you

    Disclaimer: FinancialTradeFreedom.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 financialtradefreedom.com | All Rights Reserved